4.3. risk factors relapse clinical stage testicular cancer. cs seminoma germ cell tumour (sgct), primary tumour size stromal invasion rete testis identified associated relapse risk pooled analysis retrospective data . absence factors associated low risk recurrence (6%) . whilst original analysis supported subsequent retrospective report , prospective series [34-36] supported prognostic significance tumour size stromal invasion rete testis. two srs assessed prognostic value risk factors . tumour size (continuous dichotomised) rete testis invasion associated higher risk relapse, srs highlighted low quality studies included concluded level evidence low able recommend use risk factors drive adjuvant treatment decisions . cs nsgct, invasion primary tumour blood lymphatic vessels, (i.e. lymphovascular invasion (lvi)), strongly associated risk relapse disease [39-41]. risk factors level validation prognostic significance . interobserver agreement variable, immunohistochemistry vascular markers may improve detection lvi . percentage embryonal carcinoma within tumour may enhance positive predictive value (ppv) negative predictive value (npv) lvi , definitive prognostic cut-off percentage . risk relapse five years according historical figures, patients lvi-positive tumours 50% vs. 15% patients lvi-negative tumours. table 3: pathological risk-factors occult metastatic disease clinical stage testicular cancer histological typeseminoma non-seminoma • pathological risk-factors• tumour size• invasion rete testis• lympho-vascular invasion inperi-tumoral tissue